Infectious causes of acute flaccid paralysis

Current Opinion in Infectious Diseases

Volumn 16, Issue 5, 2003, Pages 375-381

  Solomon, Tom ^a   Willison, Hugh ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Acute inflammatory demyelinating polyneuropathy; Acute motor axonal neuropathy; Antiganglioside antibodies; Enterovirus 71; Flavivirus; Guillain Barr syndrome; Japanese encephalitis; Poliomyelitis; West Nile encephalitis

Indexed keywords

BACTERIUM ANTIBODY; GANGLIOSIDE;

ACUTE DISEASE; ASIA; BLOOD GROUP TYPING; BLOOD TRANSFUSION; BRAIN RADIOGRAPHY; CAMPYLOBACTER JEJUNI; DATA ANALYSIS; DEMYELINATING DISEASE; DISEASE SEVERITY; ENCEPHALITIS; ENTEROVIRUS; ENTEROVIRUS 71; EPIDEMIC; ERADICATION THERAPY; FLACCID PARALYSIS; GUILLAIN BARRE SYNDROME; HUMAN; INFECTION; INFLAMMATION; MOTOR NERVE; MYELIN SHEATH; NERVE FIBER; NERVE FIBER MEMBRANE; NEUROPHYSIOLOGY; NONHUMAN; ORGAN TRANSPLANTATION; PARKINSON DISEASE; PATHOLOGY; PERIPHERAL NERVE; POLIOMYELITIS; POLYNEUROPATHY; REVIEW; SCHWANN CELL; SENSORY NERVE; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS;

ACUTE DISEASE; ENTEROVIRUS INFECTIONS; GUILLAIN-BARRE SYNDROME; HUMANS; MUSCLE HYPOTONIA; PARALYSIS; WEST NILE FEVER;

EID: 0142043922     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200310000-00002     Document Type: Review

References (80)

1. Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of GuillainBarré polyneuropathy. Brain 1986; 109:1115-1126.
2. Bolton CF. The changing concepts of Guillain-Barré syndrome. New Engl J Med 1995; 333:1415-1416.
3. McKhann GM, Cornblath DR, Ho T, et al. Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet 1991; 338:593-597.
4. Jacobs BC, Rothbarth PH, van der Meche FG, et al. The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study. Neurology 1998; 51:1110-1115.
5. Winer JB, Hughes RA, Anderson MJ, et al. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 1988; 51:613-618.
6. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993; 33:333-342.
7. Rees JHR, Soudain SE, Gregson NA, et al. Campylobacter jejuni infection and Guillain-Barré syndrome. New Engl J Med 1995; 333:1374-1379.
8. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002; 125:2591-2625. A comprehensive review on the rale of anti-glycolipid antibodies in neuropathy, from their original discovery 20 years ago in immunoglobulin M paraproteinaemic neuropathy through to current discoveries mapping their relationship to subtypes of GBS.
9. Yuki N, Taki T, Inagaki F, et al. A bacterium lipopolysaccharide that elicits Guillain-Barre syndrome has a GM1 ganglioside-like structure. J Exp Med 1993; 178:1771-1775.
10. Willison HJ, Kennedy PGE. Gangliosides and bacterial toxins in Guillain-Barré syndrome. J Neuroimmunology 1993; 46:105-112.
11. Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes. Lancet Infect Dis 2001; 1:29-37.
12. Tsai TF, Popovici F, Cernescu C, et al. West Nile encephalitis epidemic in southeastern Romania. Lancet 1998; 352:767-771.
13. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001; 344:1807-1814.
14. Petersen LR, Roehrig JT, Hughes JM. West Nile virus encephalitis. N Engl J Med 2002; 347:1225-1226.
15. Solomon T, Ooi MH, Beasley DW, et al. West Nile encephalitis. BMJ 2003; 326:865-869.
16. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001; 358:261-264.
17. Asnis DS, Conetta R, Teixeira AA, et al. The West Nile virus outbreak of 1999 in New York: the Flushing Hospital experience. Clin Infect Dis 2000; 30:413-418.
18. Ahmed S, Libman R, Wesson K, et al. Guillain-Barre syndrome: An unusual presentation of West Nile virus infection. Neurology 2000; 55:144-146.
19. Solomon T, Kneen R, Dung NM, et al. Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet 1998; 351:1094-1097.
20. Solomon T, Vaughn DW. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. In: Mackenzie JS, Barrett AD, Deubel V, editors. Current topics in microbiology and immunology: Japanese encephalitis and West Nile virus infections. Berlin: Springer-Verlag 2002: 171-194. This is a detailed review comparing the pathogenesis and clinical features of West Nile virus and Japanese encephalitis virus.
21. Leis AA, Stokic DS, Polk JL, et al. A poliomyelitis-like syndrome from West Nile virus infection. N Engl J Med 2002; 347:1279-1280.
22. Glass JD, Samuels O, Rich MM. Poliomyelitis due to West Nile virus. N Engl J Med 2002; 347:1280-1281.
23. Sejvar JJ, Leis AA, Stokic DS, et al. Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis [online serial] 2003; 9:03-0129. http:// www.cdc.gov/ncidod/EID/vol9no7/03-0129.htm. [Accessed July 2003] These authors provide a clinical and neurophysiological description of seven patients with poliomyelitis-like illness due to West Nile virus.
24. Li J, Loeb JA, Shy ME, et al. Asymmetric flaccid paralysis: A neuromuscular presentation of West Nile virus infection. Ann Neurol 2003; 53:703-710.
25. Kelley TW, Prayson RA, Isada CM. Spinal cord disease in West Nile virus infection (letter). N Engl J Med 2003; 348:564-566.
26. Leis AA, Fratkin J, Stokic DS, et al. West Nile poliomyelitis. Lancet Infect Dis 2003; 3:9-10.
27. Misra UK, Kalita J. Anterior horn cells are also involved in Japanese encephalitis. Acta Neurol Scand 1997; 96:114-117.
28. Burrow JN, Whelan PI, Kilburn CJ, et al. Australian encephalitis in the Northern Territory: clinical and epidemiological features, 1987-1996. Aust N Z J Med 1998; 28:590-596.
29. Schellinger PD, Schmutzhard E, Fiebach JB, et al. Poliomyelitic-like illness in central European encephalitis. Neurology 2000; 55:299-302.
30. Gadoth N, Weitzman S, Lehmann EE. Acute anterior myelitis complicating West Nile fever. Arch Neural 1979; 36:172-173.
31. Breinl A. Clinical pathological and experimental observations on the "mysterious disease", a clinically aberrant form of poliomyelitis. Med J Aust 1918; 1:209-229.
32. McClean DM, Stevenson WJ. Serological studies on the relationship between Australian X disease and the virus of Murray Valley encephalitis. Med J Aust 1954; 1:636-637.
33. Hawkes RA. Murray Valley encephalitis and related infections. In: Porterfield JS, editor. Exotic viral infections. London: Chapman & Hall; 1985. pp. 175-181.
34. World Health Assembly. Global eradication of poliomyelitis by the year 2000. Geneva: World Health Organization; 1988.
35. World Health Organization. Acute onset flaccid paralysis. Geneva: World Health Organization; 1993.
36. John TJ. Spinal cord disease in West Nile virus infection (Letter). N Engl J Med 2003; 348:564-566.
37. Johnson RT, Cornblath DR. Poliomyelitis and flaviviruses. Ann Neurol 2003; 53:691-692.
38. Solomon T, Ravi V. Acute flaccid paralysis caused by West Nile virus (Letter). Lancet Infect Dis 2003; 3:189.
39. Solomon T, Fisher AF, Beasley DW, et al. Natural and nosocomial infection in a patient with West Nile encephalitis and extrapyramidal movement disorders. Clin Infect Dis 2003; 36:E140-E145.
40. Sampson BA, Ambrosi C, Charlot A, et al. The pathology of human West Nile Virus infection. Human Pathol 2000; 31:527-531.
41. West Nile virus activity: United States, October 10-16, 2002, and update on West Nile virus infections in recipients of blood transfusions. MMWR Morb Mortal Wkly Rep 2002; 51:929-931.
42. Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348:2196-2203. In this extremely thorough epidemiological investigation of a unique episode, transmission in infected blood products, infected organs, and the high susceptibility of people on immunosuppressive drugs was demonstrated.
43. Possible West Nile virus transmission to an infant through breast-feeding: Michigan, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:877-878.
44. Provisional surveillance summary of the West Nile virus epidemic: United States, January-November 2002. MMWR Morb Mortal Wkly Rep 2002; 51:1129-1133.
45. Anderson JF, Rahal JJ. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis 2002; 8:107-108.
46. Rahal J, Anderson J, Rosenberg C, et al. Effect of interferon alpha-2b on St. Louis (SL) virus meningoencephalitis: clinical and laboratory results [abstract]. In: Program and Abstracts of Infectious Diseases Society of America, 40th Meeting; 2002; Chicago, IL Infectious Diseases Society of America, p. 823.
47. Harinasuta C, Nimmanitya S, Titsyakorn U. The effect of interferon alpha on two cases of Japanese encephalitis in Thailand. SE Asian J Trop Med Pub Health 1985; 16:332-336.
48. Solomon T, Dung NM, Wills B, et al. Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet 2003; 361:821-826.
49. Diamond MS, Shrestha B, Marri A, et al. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 2003; 77:2578-2586.
50. Ben-Nathan D, Lustig S, Tam G, et al. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J Infect Dis 2003; 188:5-12.
51. Lanciotti RS, Ebel GD, Deubel V, et al. Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology 2002; 298:96-105.
52. Burt FJ, Grobbelaar AA, Leman PA, et al. Phylogenetic relationships of southern African West Nile virus isolates. Emerg Infect Dis 2002; 8:820-826. Phylogenetic analysis of a broad range of West Nile virus isolates from lineages I and II, confirmed that lineage II isolates have been associated with severe disease in humans.
53. Beasley DW, Li L, Suderman MT, et al. Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 2002; 296:17-23.
54. Mashimo T, Lucas M, Simon-Chazottes D, et al. A nonsense mutation in the gene encoding 2′-5′-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci U S A 2002; 99:11311-11316. A genetic locus determining susceptibility/resistance to West Nile virus infection in mice was mapped to chromosome 5, where a cluster of genes encoding a family of interferon-inducible proteins. The implication is that, in animal models at least, a point mutation in a single gene may determine host susceptibility to West Nile virus infection.
55. Progress toward global eradication of poliomyelitis, 2002. MMWR Morb Mortal Wkly Rep 2003; 52:366-369.
56. Progress toward poliomyelitis eradication: India, 2002. MMWR Morb Mortal Wkly Rep 2003; 52:172-175.
57. Kohler KA, Hlady WG, Banerjee K, et al. Outbreak of poliomyelitis due to type 3 poliovirus, northern India, 1999-2000: injections a major contributing factor, Int J Epidemiol 2003; 32:272-277.
58. Wyatt HV. Provocation of poliomyelitis by multiple injections. Trans R Soc Trop Med Hyg 1985; 79:355-358.
59. Rekand T, Langeland N, Aarli JA, et al. Fcgamma receptor IIIA polymorphism as a risk factor for acute poliomyelitis. J Infect Dis 2002; 186:1840-1843.
60. Cardosa MJ, Krishnan S, Tio PH, et al. Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak. Lancet 1999; 354:987-991.
61. Chang LY, Lin TY, Hsu KH, et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 1999; 354:1682-1686.
62. Huang CC, Liu CC, Chang YC, et al. Neurologic complications in children with enterovirus 71 infection. New Engl J Med 1999; 341:936-942.
63. McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 2002; 26:91-107.
64. Nolan MA, Craig ME, Lahra MM, et al. Survival after pulmonary edema due to enterovirus 71 encephalitis. Neurology 2003; 60:1651-1656.
65. Shen WC, Tsai C, Chiu H, et al. MRI of Enterovirus 71 myelitis with monoplegia. Neuroradiology 2000; 42:124-127.
66. Chen CY, Chang YC, Huang CC, et al. Acute flaccid paralysis in infants and young children with enterovirus 71 infection: MR imaging findings and clinical correlates. AJNR Am J Neuroradiol 2001; 22:200-205.
67. Hsueh C, Jung S-M, Shih S-R, et al. Acute encephalomyelitis during an outbreak of enterovirus type 71 Infection in Taiwan: report of an autopsy case with pathologic, immunofluorescence, and molecular studies. Mod Pathol 2000; 13:1200-1205.
68. McMinn P, Stratov I, Nagarajan L, et al. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis 2001; 32:236-242.
69. Chan LG, Parashar UD, Lye MS, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis 2000; 31:678-683.
70. Ho M, Chen ER, Hsu KH, et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 1999; 341:929-935.
71. Lum LC, Wong KT, Lam SK, et al. Fatal enterovirus 71 encephalomyelitis. J Pediatr 1998; 133:795-798.
72. Wang SM, Liu CC, Tseng HW, et al. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis 1999; 29:184-190.
73. Lin TY, Chang LY, Hsia SH, et al. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis 2002; 34 (Suppl 2):S52-S57.
74. Huang FL, Jan SL, Chen PY, et al. Left ventricular dysfunction in children with fulminant enterovirus 71 infection: an evaluation of the clinical course. Clin Infect Dis 2002; 34:1020-1024.
75. Yan JJ, Wang JR, Liu CC, et al. An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis. J Clin Virol 2000; 17:13-22.
76. Wu JM, Wang JN, Tsai YC, et al. Cardiopulmonary manifestations of fulminant enterovirus 71 infection. Pediatrics 2002; 109:E26 This detailed haemodynamic study marks the way forward for resolving controversies such as the cause of pulmonary oedema in enterovirus 71 infection. In the patients studied there was little to suggest increased hydrostatic pressure in the pulmonary vasculature.
77. Lin TY, Hsia SH, Huang YC, et al. Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin Infect Dis 2003; 36:269-274.
78. McMinn P, Lindsay K, Perera D, et al. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol 2001; 75:7732-7738.
79. Wang JR, Tuan YC, Tsai HP, et al. Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J Clin Microbiol 2002; 40:10-15.
80. Cardosa MJ, Perera D, Brown BA, et al. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis 2003; 9:461-468.